January 26, 2024 06:45 AM ESTUpdated January 30, 04:01 PM
People
Peer Review

Bay­er’s ra­di­ol­o­gy head plans re­tire­ment; Ex-Sanofi chief Olivi­er Brandi­court joins BeiGene’s board

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Gerd Krueger will re­tire as head of the ra­di­ol­o­gy busi­ness at Bay­er’s phar­ma­ceu­ti­cal di­vi­sion, and Nel­son Am­bro­gio has been named …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times